GlassScriptPhysician profile
Suzanne M Barnhart
NPI 1639231616
$3,967.13
in general payments reported to CMS, 2019-2025
35 companies · $72.14 in 2025
The $72.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $428 · 2021: $634 · 2022: $712 · 2023: $1,548 · 2024: $184 · 2025: $72.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452 · Education: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.54 |
| Education | $352.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $609.85 | 2019-2025 | Veozah |
| Abbvie INC. | $547.37 | 2020-2023 | Orilissa, Lo Loestrin Fe, Ubrelvy |
| Myriad Women'S Health, INC. | $535.33 | 2023 | Myrisk |
| Aspira Women'S Health INC | $322.03 | 2022-2023 | Ova1 |
| Pfizer INC. | $230.30 | 2019-2023 | |
| Daiichi Sankyo INC. | $205.09 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $197.37 | 2021-2023 | |
| Minerva Surgical, INC | $183.53 | 2019-2023 | |
| Exeltis, USA INC. | $146.21 | 2022-2023 | Slynd |
| Myovant Sciences INC. | $107.62 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $100.79 | 2023 | Myfembree |
| Amgen INC. | $77.01 | 2020-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $75.32 | 2021-2023 | |
| Therapeuticsmd, INC. | $70.33 | 2020-2022 | |
| Hologic Sales and Service, LLC | $63.39 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $49.12 | 2019-2020 | |
| Conmed Corporation | $48.85 | 2019 | |
| Vertical Pharmaceuticals, LLC | $48.36 | 2019-2020 | |
| Avion Pharmaceuticals | $36.10 | 2019-2021 | |
| Becton, Dickinson and Company | $35.75 | 2021 | |
| Mylan Pharmaceuticals INC. | $35.10 | 2021-2022 | |
| Duchesnay USA Incorporated | $27.53 | 2019 | |
| Bard Access Systems, INC. | $26.09 | 2019 | |
| Sanara Medtech INC. | $23.40 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $20.92 | 2021 | |
| Abbott Laboratories | $20.42 | 2024 | Freestyle Libre 3 |
| Ethicon US, LLC | $18.88 | 2019 | |
| Evofem Biosciences, INC. | $16.63 | 2021 | |
| Merck Sharp & Dohme LLC | $14.91 | 2021 | |
| Optumhealth Care Solutions, LLC | $14.16 | 2023 | Vivify Health Care Team Portal |
| Medtronic, INC. | $13.89 | 2022 | |
| Novo Nordisk INC | $12.17 | 2020 | |
| Coopersurgical, INC. | $11.25 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.17 | 2019 | |
| Roche Diagnostics Corporation | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Barnhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.